HRP20050917B1 - Postupak za dobivanje kristaliniäśnog ciklesonida s definiranom veliäśinom äśestica - Google Patents

Postupak za dobivanje kristaliniäśnog ciklesonida s definiranom veliäśinom äśestica

Info

Publication number
HRP20050917B1
HRP20050917B1 HRP20050917AA HRP20050917A HRP20050917B1 HR P20050917 B1 HRP20050917 B1 HR P20050917B1 HR P20050917A A HRP20050917A A HR P20050917AA HR P20050917 A HRP20050917 A HR P20050917A HR P20050917 B1 HRP20050917 B1 HR P20050917B1
Authority
HR
Croatia
Prior art keywords
particle size
crystalline ciclesonide
pharmaceutical compositions
preparing crystalline
defined particle
Prior art date
Application number
HRP20050917AA
Other languages
English (en)
Inventor
Beate Schmidt
Stefan Kaupp
Ernst Sturm
Klaus Eistetter
Original Assignee
Takeda Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33099298&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20050917(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Gmbh filed Critical Takeda Gmbh
Publication of HRP20050917A2 publication Critical patent/HRP20050917A2/xx
Publication of HRP20050917B1 publication Critical patent/HRP20050917B1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F21/00—Dissolving

Abstract

Izum se odnosi na nove postupke za dobivanje kristaliničnog ciklesonida s pogodnom veličinom čestica i raspodjelom veličine čestica i na njegovu upotrebu u proizvodnji farmaceutskih pripravaka, posebice za topikalnu upotrebu. Kristalinični ciklesonid dobiven novim postupkom ima povoljna aerodinamička svojstva, i može se dalje procesirati u inhalacijske farmaceutske pripravke ili farmaceutske pripravke za nazalnu primjenu, bez daljnje mehaničke mikronizacije.
HRP20050917AA 2003-03-27 2005-10-19 Postupak za dobivanje kristaliniäśnog ciklesonida s definiranom veliäśinom äśestica HRP20050917B1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10314097 2003-03-27
EP03007007 2003-03-27
PCT/EP2004/050373 WO2004085460A1 (en) 2003-03-27 2004-03-26 Process for preparing crystalline ciclesonide with defined particle size

Publications (2)

Publication Number Publication Date
HRP20050917A2 HRP20050917A2 (en) 2006-12-31
HRP20050917B1 true HRP20050917B1 (hr) 2014-02-14

Family

ID=33099298

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20050917AA HRP20050917B1 (hr) 2003-03-27 2005-10-19 Postupak za dobivanje kristaliniäśnog ciklesonida s definiranom veliäśinom äśestica

Country Status (28)

Country Link
US (1) US9422327B2 (hr)
EP (1) EP1611150B1 (hr)
JP (1) JP4746535B2 (hr)
KR (1) KR101102709B1 (hr)
AR (1) AR043579A1 (hr)
AT (1) ATE546459T1 (hr)
AU (1) AU2004224092B2 (hr)
BR (1) BRPI0408569B1 (hr)
CA (1) CA2519752C (hr)
CL (1) CL2004000636A1 (hr)
CY (1) CY1112970T1 (hr)
DK (1) DK1611150T3 (hr)
EA (1) EA011157B1 (hr)
ES (1) ES2382928T3 (hr)
HK (1) HK1088905A1 (hr)
HR (1) HRP20050917B1 (hr)
IL (1) IL170746A (hr)
MX (1) MXPA05010041A (hr)
MY (1) MY143936A (hr)
NO (1) NO331984B1 (hr)
NZ (1) NZ542827A (hr)
PE (1) PE20050388A1 (hr)
PL (1) PL1611150T3 (hr)
PT (1) PT1611150E (hr)
RS (1) RS52549B (hr)
SI (1) SI1611150T1 (hr)
TW (1) TWI328589B (hr)
WO (1) WO2004085460A1 (hr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070135398A1 (en) * 2005-11-02 2007-06-14 Pierluigi Rossetto Process for the preparation of ciclesonide
EP1904514A2 (en) * 2006-02-08 2008-04-02 Sicor, Inc. Crystalline forms of ciclesonide
WO2008015696A2 (en) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Process for preparing ciclesonide
WO2008062450A2 (en) * 2006-09-18 2008-05-29 Cadila Healthcare Limited Crystalline polymorphs of ciclesonide
JP2010503722A (ja) 2006-09-19 2010-02-04 シプラ・リミテッド シクレソニドとその結晶変異体の調製方法
EP2262823B1 (en) * 2008-03-13 2013-01-23 Farmabios S.p.A. Process for the preparation of pregnane derivatives
IT1397499B1 (it) * 2009-01-09 2013-01-16 Farmabios Spa Processo per la preparazione di ciclesonide
US20100120733A1 (en) * 2008-11-07 2010-05-13 Auspex Pharmaceuticals, Inc. Steroid modulators of glucocorticoid receptor
US9109005B2 (en) 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
WO2014007781A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions
WO2014007772A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising glucose anhydrous
WO2014007770A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising corticosteroid and sorbitol
MY194619A (en) 2016-06-02 2022-12-07 Abbvie Inc Glucocorticoid receptor agonist and immunoconjugates thereof
CN111417410B (zh) 2017-12-01 2023-06-23 艾伯维公司 糖皮质激素受体激动剂及其免疫缀合物

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605517A (en) * 1983-10-29 1986-08-12 Sterling Drug Inc. Method of preparing steroid compounds of controlled particle size
DE19635498A1 (de) * 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
WO2001000046A1 (de) * 1999-06-25 2001-01-04 Cognis Deutschland Gmbh Verwendung von nanoskaligen sterolen und sterolestern
WO2002038584A1 (en) * 2000-11-10 2002-05-16 Altana Pharma Ag Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation
US6482438B1 (en) * 1998-12-24 2002-11-19 Smithkline Beecham Corporation Apparatus and process for preparing crystalline particles

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU624421B2 (en) 1988-10-05 1992-06-11 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
DE407028T1 (de) 1989-05-31 1994-03-17 Fisons Plc Medikament und Inhalationsvorrichtung dafür.
GR1001529B (el) 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
FR2668945B1 (fr) 1990-11-12 1993-02-19 Theramex Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus.
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
CZ287877B6 (cs) 1993-04-02 2001-03-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Prednisolonové deriváty a farmaceutické prostředky s jejich obsahem
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of drug patramulations
DE59508898D1 (de) 1994-03-09 2001-01-18 Byk Gulden Lomberg Chem Fab Neue silylverbindungen und ihre verwendung
DE19541689A1 (de) 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
US6120752A (en) 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
GB9722285D0 (en) 1997-10-23 1997-12-17 Rhone Poulenc Rorer Ltd Inhalation device
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
NZ509328A (en) * 1998-07-24 2002-11-26 Jago Res A Medicinal aerosol formulations
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605517A (en) * 1983-10-29 1986-08-12 Sterling Drug Inc. Method of preparing steroid compounds of controlled particle size
DE19635498A1 (de) * 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
US6482438B1 (en) * 1998-12-24 2002-11-19 Smithkline Beecham Corporation Apparatus and process for preparing crystalline particles
WO2001000046A1 (de) * 1999-06-25 2001-01-04 Cognis Deutschland Gmbh Verwendung von nanoskaligen sterolen und sterolestern
WO2002038584A1 (en) * 2000-11-10 2002-05-16 Altana Pharma Ag Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21-dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation

Also Published As

Publication number Publication date
AR043579A1 (es) 2005-08-03
EA200501391A1 (ru) 2006-06-30
NZ542827A (en) 2008-02-29
WO2004085460A1 (en) 2004-10-07
RS52549B (en) 2013-04-30
SI1611150T1 (sl) 2012-06-29
ATE546459T1 (de) 2012-03-15
NO20054835L (no) 2005-10-19
RS20050704A (en) 2007-06-04
CL2004000636A1 (es) 2005-02-04
AU2004224092A1 (en) 2004-10-07
EP1611150A1 (en) 2006-01-04
KR20050114250A (ko) 2005-12-05
CY1112970T1 (el) 2016-04-13
MY143936A (en) 2011-07-29
WO2004085460A8 (en) 2007-03-15
PE20050388A1 (es) 2005-05-30
MXPA05010041A (es) 2005-11-17
HRP20050917A2 (en) 2006-12-31
NO331984B1 (no) 2012-05-21
PT1611150E (pt) 2012-05-07
IL170746A0 (en) 2009-02-11
HK1088905A1 (en) 2006-11-17
KR101102709B1 (ko) 2012-01-05
DK1611150T3 (da) 2012-05-14
EP1611150B1 (en) 2012-02-22
US9422327B2 (en) 2016-08-23
JP4746535B2 (ja) 2011-08-10
TW200418519A (en) 2004-10-01
TWI328589B (en) 2010-08-11
IL170746A (en) 2012-06-28
CA2519752C (en) 2012-05-29
JP2006521332A (ja) 2006-09-21
US20060128954A1 (en) 2006-06-15
EA011157B1 (ru) 2009-02-27
CA2519752A1 (en) 2004-10-07
AU2004224092B2 (en) 2010-03-04
PL1611150T3 (pl) 2012-07-31
BRPI0408569A (pt) 2006-03-21
BRPI0408569B1 (pt) 2017-08-29
ES2382928T3 (es) 2012-06-14

Similar Documents

Publication Publication Date Title
HRP20050917A2 (en) Process for preparing crystalline ciclesonide with defined particle size
HRP20050735B1 (hr) Dihidropteridinoni, metoda za njihovu proizvodnju i upotrebu u obliku lijekova
TW200621262A (en) New dihydropteridione derivatives, process for their manufacture and their use as medicament
MY147262A (en) 1-aza-bicyclo[3.3.1]nonanes
WO2007124153A3 (en) Water-soluble pharmaceutical compositions of hops resins
TN2015000007A1 (en) 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
MX336225B (es) Composiciones que comprenden sulfato de salbutamol.
CN103230356A (zh) 一种金钗石斛牙膏
SE0950390L (sv) System och process för tillverkning av en lösning med suspenderade fasta ämnen och användningar därför
IN2012DN00239A (hr)
WO2006041843A3 (en) Pharmaceutical dosage form comprising meloxicam
CN103181880A (zh) 天然防脱发洗发水及其制作工艺
US20150174245A1 (en) Transparent gel
CN103417440A (zh) 一种丰胸精油
CN102526104A (zh) 一种复方治疗脚气药液及其制备方法
WO2007043094A3 (en) 6-vinyl pyrimidine and pyrimidinone derivatives and the use thereof
CN108126045B (zh) 一种纳米二氧化硅复方中药及其应用
CN103156913A (zh) 一种用于疏散表邪清热化湿的中药药物组合及其制备方法
AU2011304261A8 (en) Antimicrobial and anti-inflammatory action pharmaceutical composition for parenteral administration, process of producing the same
Muniyappan et al. Synthesis of Silver Nanoparticles Using Dalbergia rubiginosa Root Aqueous Extract
CN102949316A (zh) 一种甲壳素润肤液
CN104224830A (zh) 一种治疗皮肤湿疹的凝胶剂
Alizadeh et al. Study of antioxidant activity and total phenolic content of 22 plants from Compositae family
Santos et al. Characterization and in vitro evaluation of a new chitosan-based propolis tooth varnish

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: NYCOMED GMBH, DE

PNAN Change of the applicant name, address/residence

Owner name: TAKEDA GMBH, DE

B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: NYCOMED ASSET MANAGEMENT GMBH, DE

Owner name: NYCOMED GERMANY HOLDING GMBH, DE

Owner name: TAKEDA GMBH, DE

PPPP Transfer of rights

Owner name: ASTRAZENECA AB, SE

ODRP Renewal fee for the maintenance of a patent

Payment date: 20190207

Year of fee payment: 16

PPPP Transfer of rights

Owner name: COVIS PHARMA B.V., CH

ODRP Renewal fee for the maintenance of a patent

Payment date: 20200206

Year of fee payment: 17

ODRP Renewal fee for the maintenance of a patent

Payment date: 20210326

Year of fee payment: 18

ODRP Renewal fee for the maintenance of a patent

Payment date: 20220324

Year of fee payment: 19

PPPP Transfer of rights

Owner name: COVIS PHARMA GMBH, CH

ODRP Renewal fee for the maintenance of a patent

Payment date: 20230207

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20240326